• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病患者血清腺苷脱氨酶水平:一项前瞻性病例对照研究。

Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study.

作者信息

Bukulmez G, Akan T, Ciliv G

机构信息

University Faculty of Medicine, Department of Dermatology, Ankara, Turkey 06100, USA.

出版信息

Eur J Dermatol. 2000 Jun;10(4):274-6.

PMID:10846253
Abstract

Adenosine deaminase (ADA) activity is a nonspecific marker of T cell activation. T cell activation is thought to play an important role in the pathogenesis of psoriasis. Our purpose was to assess the significance of serum ADA activity in psoriasis and its relevance to disease activity. ADA activity was determined with an enzymatic method in 25 patients with psoriasis and in 15 healthy subjects. These measurements were repeated for 10 patients after either PUVA or cyclosporin A treatments. Disease activity was estimated by the PASI scoring system. Serum ADA level was significantly elevated in patients with psoriasis compared to healthy subjects (p<0.05). There was a significant decrease in the ADA levels after treatment compared to pretreatment values in the same patients (p<0.05). There was no correlation between ADA levels and PASI scores. These results support the evidence that T cell activation is involved in the pathogenesis of psoriasis and that ADA may be valuable in the assessment of disease activity in psoriasis.

摘要

腺苷脱氨酶(ADA)活性是T细胞活化的非特异性标志物。T细胞活化被认为在银屑病的发病机制中起重要作用。我们的目的是评估血清ADA活性在银屑病中的意义及其与疾病活动度的相关性。采用酶法测定了25例银屑病患者和15名健康受试者的ADA活性。对其中10例患者在接受补骨脂素加紫外线A(PUVA)或环孢素A治疗后重复进行了这些测量。通过银屑病面积和严重程度指数(PASI)评分系统评估疾病活动度。与健康受试者相比,银屑病患者的血清ADA水平显著升高(p<0.05)。与同一患者治疗前的值相比,治疗后ADA水平显著降低(p<0.05)。ADA水平与PASI评分之间无相关性。这些结果支持了T细胞活化参与银屑病发病机制以及ADA可能在评估银屑病疾病活动度方面具有价值的证据。

相似文献

1
Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study.银屑病患者血清腺苷脱氨酶水平:一项前瞻性病例对照研究。
Eur J Dermatol. 2000 Jun;10(4):274-6.
2
CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.银屑病患者在接受环孢素、依那西普和补骨脂素加紫外线 A 光疗治疗后,血清中 CD26/二肽基肽酶 IV 和腺苷脱氨酶的水平。
Int J Dermatol. 2011 Aug;50(8):948-55. doi: 10.1111/j.1365-4632.2010.04799.x.
3
Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis.银屑病患者腺苷脱氨酶活性、胰蛋白酶抑制能力和总抗氧化能力。
J Eur Acad Dermatol Venereol. 2010 Mar;24(3):329-34. doi: 10.1111/j.1468-3083.2009.03416.x. Epub 2009 Sep 1.
4
Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.白塞病患者的血清及红细胞腺苷脱氨酶活性
Int J Dermatol. 2006 Sep;45(9):1053-6. doi: 10.1111/j.1365-4632.2006.02892.x.
5
Serum adenosine deaminase levels in diagnosis of acute appendicitis.血清腺苷脱氨酶水平在急性阑尾炎诊断中的应用
Emerg Med J. 2008 Sep;25(9):583-5. doi: 10.1136/emj.2007.054452.
6
[Serum adenosine deaminase activity in pulmonary tuberculosis].[肺结核患者血清腺苷脱氨酶活性]
Tuberk Toraks. 2003;51(3):277-81.
7
[Role of serum adenosine deaminase as an immune parameter of tuberculosis].[血清腺苷脱氨酶作为结核病免疫参数的作用]
Pneumologie. 1995 Dec;49(12):684-8.
8
[Cytokine production-adenosine deaminase activity relationship in pulmonary tuberculosis].[肺结核中细胞因子产生与腺苷脱氨酶活性的关系]
Probl Tuberk. 2000(3):38-41.
9
Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India.印度内脏利什曼病患者血清中的腺苷脱氨酶活性
Clin Chim Acta. 2008 Feb;388(1-2):135-8. doi: 10.1016/j.cca.2007.10.022. Epub 2007 Oct 30.
10
[Activity of adenosine deaminase in acute brucellosis and complicated brucellosis].[急性布鲁氏菌病及复杂性布鲁氏菌病中腺苷脱氨酶的活性]
Med Clin (Barc). 1991 Mar 30;96(12):445-8.

引用本文的文献

1
Evaluation of Serum Adenosine Deaminase and Inflammatory Markers in Psoriatic Patients.银屑病患者血清腺苷脱氨酶及炎症标志物的评估
Indian J Dermatol. 2019 May-Jun;64(3):207-212. doi: 10.4103/ijd.IJD_420_17.
2
Correlations between related-purine derivatives and renal disorders in patients with psoriasis vulgaris.寻常型银屑病患者相关嘌呤衍生物与肾脏疾病之间的相关性。
Exp Ther Med. 2019 Feb;17(2):1012-1019. doi: 10.3892/etm.2018.7053. Epub 2018 Dec 5.
3
Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients.
评估ADA活性作为银屑病患者疾病严重程度的潜在标志物。
Psoriasis (Auckl). 2018 Sep 4;8:59-63. doi: 10.2147/PTT.S174119. eCollection 2018.
4
Adenosine: an endogenous mediator in the pathogenesis of psoriasis.腺苷:银屑病发病机制中的内源性介质。
An Bras Dermatol. 2015 Nov-Dec;90(6):862-7. doi: 10.1590/abd1806-4841.20153689.
5
Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances.天然物质对腺苷脱氨酶(ADA)介导的蛹虫草苷代谢的抑制作用。
Pharmacol Res Perspect. 2015 Mar;3(2):e00121. doi: 10.1002/prp2.121. Epub 2015 Feb 10.
6
Evaluation of adenosine deaminase assay for analyzing T-lymphocyte density in vitro.用于体外分析T淋巴细胞密度的腺苷脱氨酶测定法的评估
In Vitro Cell Dev Biol Anim. 2006 Nov-Dec;42(10):287-9. doi: 10.1290/0602012.1.
7
Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.白塞病患者腺苷脱氨酶活性增加,且与过氧化氢酶、超氧化物歧化酶和谷胱甘肽过氧化物酶呈负相关:原创性贡献/临床与实验室研究
Mediators Inflamm. 2003 Apr;12(2):107-16. doi: 10.1080/0962935031000097754.